Femasys (FEMY) Return on Capital Employed (2021 - 2025)
Femasys (FEMY) reported Return on Capital Employed of 746.57% for Q2 2025, down 66361.0% on a YoY basis from N/an in Q2 2024, and down 13.97% quarter-over-quarter from 655.03% in Q1 2025.
Femasys (FEMY) Return on Capital Employed (2021 - 2025) Analysis & Trends
Femasys has reported Return on Capital Employed for 5 years, with the latest figure at 746.57% in Q2 2025.
- For the quarter ending Q2 2025, Return on Capital Employed fell 66361.0% year-over-year to 746.57%; the trailing twelve-month figure through Jun 2025 stood at 746.57% (down 66361.0% YoY), and the FY2025 full-year result was 135.84%, up 1859.0% from the prior year.
- Return on Capital Employed for Q2 2025 stood at 746.57%, down from 655.03% in the prior quarter.
- The five-year high for Return on Capital Employed was 24.85% in Q3 2021, with the low at 746.57% in Q2 2025.
- Historically, Return on Capital Employed has averaged 163.46% across 5 years, with a median of 81.23% in 2023.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 2120 bps — and 2025, when it plunged 66361 bps.
- Femasys' Return on Capital Employed stood at 29.59% in 2021, then slumped by 132 bps to 68.49% in 2022, then dropped by 16 bps to 79.5% in 2023, then tumbled by 312 bps to 327.42% in 2024, then slumped by 128 bps to 746.57% in 2025.
- The last three Return on Capital Employed figures came in at 746.57% (Q2 2025), 655.03% (Q1 2025), and 327.42% (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 5.02% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 25.95% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 18.63% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 19.44% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 4.68% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 12.74% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.02% |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -746.57% |
| Mar 31, 2025 | -655.03% |
| Dec 31, 2024 | -327.42% |
| Sep 30, 2024 | -116.26% |
| Jun 30, 2024 | -82.96% |
| Mar 31, 2024 | -62.98% |
| Dec 31, 2023 | -79.50% |
| Sep 30, 2023 | -105.34% |
| Jun 30, 2023 | -94.69% |
| Mar 31, 2023 | -84.18% |
| Dec 31, 2022 | -68.49% |
| Sep 30, 2022 | -55.43% |
| Jun 30, 2022 | -45.20% |
| Mar 31, 2022 | -36.95% |
| Dec 31, 2021 | -29.59% |
| Sep 30, 2021 | -24.85% |